WA-AWS
Today, Amazon Web Services (AWS), an Amazon.com company (NASDAQ: AMZN), and the German Bundesliga will debut the first two Bundesliga Match Facts powered by AWS during tonight’s highlight match at 18:30 CET featuring Borussia Dortmund vs. Bayern Muenchen on broadcast television in over 200 countries. The two new statistics, Average Positions and Expected Goals (xGoals), will give fans deeper insights into a team’s intended playing style based on real-time analysis performed of data captured from tracking players’ locations on the field, and the probability of a player scoring a goal. Germany’s top national football league will leverage AWS’s unmatched set of cloud services, including machine learning and analytics, to introduce additional advanced statistics in 2020 and upcoming seasons. AWS and the Bundesliga are the first to deliver this unique combination of real-time advanced statistics and game analyses to football (soccer) fans around the world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200526005205/en/
Bundesliga Match Facts are generated by gathering data from the live game video feeds that are streamed into AWS for analysis, and then provided back to broadcast viewers around the world in real-time as statistics. These statistics help audiences better understand things like the strategy involved in decision-making on the pitch and the probability of a goal for each shot. As of May 26, Average Positions will be available during future broadcasts of Bundesliga matches, while xGoals will be available during highlight matches.
A look at the two new Bundesliga Match Facts powered by AWS
Average Positions: Fans will now be able to see the positioning of a team’s players on the pitch and gain insight into the team’s intended playing style. Average Positions provides new insights based on analysis performed on data captured from tracking a player’s average location on the field, which is then displayed in real-time. This Bundesliga Match Fact allows viewers to identify the current momentum on the field and understand tactical changes. The new statistic will help pinpoint if a team is setting up in an attacking or defending style, pressing up the middle, or utilizing the wings. By displaying the average location and position of each player in real-time, Average Positions helps fans understand tactical changes as the game progresses.
xGoals : Using Amazon SageMaker, a fully managed service to build, train and deploy machine learning models, the Bundesliga can now assess the probability of a player scoring a goal when shooting from any position on the field. The goal probability is calculated in real-time for every shot to give viewers insight into the difficulty of a shot and the likelihood of a goal. To calculate the precision of xGoals, machine learning models were trained by analyzing 40,000 historical shots on goal in addition to an array of features derived from positional data, including distance to goal, angle to goal, player speed, number of defenders in line of shot, and goalkeeper coverage.
“We at Bundesliga are able to use this advanced technology from AWS, including statistics, analytics and machine learning, to interpret the data and deliver more in-depth insight and better understanding of the split-second decisions made on the pitch," said Andreas Heyden, Executive Vice President of Digital Innovations for the DFL Group. "The use of Bundesliga Match Facts enables viewers to gain a deeper insight into the key decisions in each match."
“AWS is helping the Bundesliga enhance the broadcast viewing experience by delivering deeper insights into the game that didn’t previously exist,” said Andy Isherwood, Vice President and Managing Director EMEA, AWS. “With AWS, Bundesliga is able to provide real-time statistics to predict future plays and outcomes. These two new statistics are just the beginning of what we’ll be able to deliver for football fans as we look forward to unlocking new ways to better educate, engage, and entertain viewers around the world.”
Football fans can follow all of the latest Bundesliga action, with Match Facts powered by AWS, on Bundesliga.com and via the official Facebook , Twitter , and Instagram channels.
About Amazon Web Services
For 14 years, Amazon Web Services has been the world’s most comprehensive and broadly adopted cloud platform. AWS offers over 175 fully featured services for compute, storage, databases, networking, analytics, robotics, machine learning and artificial intelligence (AI), Internet of Things (IoT), mobile, security, hybrid, virtual and augmented reality (VR and AR), media, and application development, deployment, and management from 76 Availability Zones (AZs) within 24 geographic regions, with announced plans for nine more Availability Zones and three more AWS Regions in Indonesia, Japan, and Spain. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—trust AWS to power their infrastructure, become more agile, and lower costs. To learn more about AWS, visit aws.amazon.com .
About Amazon
Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Fire tablets, Fire TV, Amazon Echo, and Alexa are some of the products and services pioneered by Amazon. For more information, visit amazon.com/about and follow @AmazonNews .
About the Bundesliga
The Bundesliga is the top professional association football league in Germany. The league was established in 1963 and comprises 18 teams which operate on a system of promotion and relegation with the Bundesliga 2. The Bundesliga is broadcast on television in over 200 countries and is operated by the DFL Deutsche Fußball Liga.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200526005205/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom